Fielmann Aktiengesellschaft Q2 2026 Earnings Recap

Fielmann’s shares rose modestly by 1.6% following earnings, reflecting cautious investor reception to a downward revision in full-year guidance amid persistent top-line challenges in its home market and a soft outlook for contact lens sales.

Key Takeaways

• Guidance was lowered last week to 2–5% revenue growth with EBITDA margin expected between 22–23%, reflecting weaker-than-expected demand rather than structural cost issues.
• First half sales grew 2.3% in constant currency (1.8% reported), with underlying organic growth at 1.7%, held back by weakness in Germany and contact lens sales declining 4%.
• EBITDA margin remained stable around 24%, buoyed by disciplined cost management despite increased personnel expenses, especially in the U.S. where margin fell 2.5%.
• International markets outside Germany showed acceleration, with Spain returning to nearly 10% growth after weather and other disruptions subsided.
• Management emphasized increased hiring and store openings to unlock growth potential, noting some pent-up demand and improved early H2 momentum, but tempered by geopolitical and macroeconomic uncertainties.